Metastatic Melanoma
2 competing products in clinical development for Metastatic Melanoma.
Pipeline by Phase
Phase 11
Phase 21
All Products (2)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| MORAb-004 (monoclonal antibody) | Eisai | Phase 2 | Completed | 35 |
| E7080 | Eisai | Phase 1 | Completed | 29 |